Affirm CEO Max Levchin on Credit Cards vs. ‘Buy Now, Pay Later’
Get every episode summarized
Each time WSJ's Take On the Week publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Affirm CEO Max Levchin is one of the original co-founders of PayPal, and now he leads one of the biggest players in the buy now, pay later business. Levchin wants to build a company that changes how shoppers pay for big-ticket items and the way people take on debt. But critics argue the company is a danger to consumers because it allows them to make some purchases with no interest payments, thereby encouraging excessive spending. For this bonus episode of WSJ’s Take On the Week, Levchin talks about Affirm’s future and competing with the credit-card industry. How can we better help you take on the week? Send us an email to [email protected].
Listening on Google Podcasts? Here's our guide for switching to a different podcast player.
Listen to WSJ’s Take On the Week: https://on.wsj.com/3r5DbS7
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time WSJ's Take On the Week publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from WSJ's Take On the Week
Making Sense of Sky-High Treasury Yields
WSJ's Take On the Week
Will Real Estate Protect Your Portfolio if the AI Bubble Bursts?
WSJ's Take On the Week
A Breakthrough Cancer Vaccine Fueled a Biotech Rally. Can It Last?
WSJ's Take On the Week
How AI Speculation Is Fueling the Small-Cap Stock Rally
WSJ's Take On the Week